Načítá se...
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
In 2014, the Food and Drug Administration approved a new human papillomavirus 9-valent vaccine (9vHPV), targeting nine HPV types: HPV types 6, 11, 16, and 18, which are also targeted by the quadrivalent HPV vaccine (qHPV), plus five additional high cancer risk HPV types (HPV types 31, 33, 45, 52, an...
Uloženo v:
| Vydáno v: | Epidemiol Infect |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cambridge University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5974698/ https://ncbi.nlm.nih.gov/pubmed/28446260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268817000747 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|